These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32381002)

  • 41. Pulmonary impairment after tuberculosis.
    Pasipanodya JG; Miller TL; Vecino M; Munguia G; Garmon R; Bae S; Drewyer G; Weis SE
    Chest; 2007 Jun; 131(6):1817-24. PubMed ID: 17400690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena.
    Ralph AP; Kenangalem E; Waramori G; Pontororing GJ; Sandjaja ; Tjitra E; Maguire GP; Kelly PM; Anstey NM
    PLoS One; 2013; 8(11):e80302. PubMed ID: 24312209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of lung function on treatment outcome in patients with TB.
    Chesov D; Butov D; Reimann M; Heyckendorf J; Myasoedov V; Butov T; Akymenko O; Lange C
    Int J Tuberc Lung Dis; 2021 Apr; 25(4):277-284. PubMed ID: 33762071
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin.
    Fiogbe AA; Agodokpessi G; Tessier JF; Affolabi D; Zannou DM; Adé G; Anagonou S; Raherison-Semjen C; Marcy O
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):195-202. PubMed ID: 30808452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis.
    Suzuki T; Shirai T; Hirai K; Tanaka Y; Watanabe H; Endo Y; Shimoda Y; Saigusa M; Akamatsu T; Yamamoto A; Morita S; Asada K
    Respir Investig; 2019 May; 57(3):252-259. PubMed ID: 30738923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary function in cured pulmonary tuberculosis cases.
    Gupta MB; Bagri S; Garg A; Singh DK; Choudhary P; Sahni S
    Indian J Tuberc; 2022 Oct; 69(4):535-538. PubMed ID: 36460385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment success rate among adult pulmonary tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis.
    Izudi J; Semakula D; Sennono R; Tamwesigire IK; Bajunirwe F
    BMJ Open; 2019 Sep; 9(9):e029400. PubMed ID: 31494610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].
    Masuyama H; Takase A; Aoki M; Shimao T
    Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Spirometric and radiographic profile of patients with pulmonary tuberculosis treated and cured at the Department of Pulmonology of Brazzaville University Hospital].
    Bemba ELP; Moyikoua R; Ouedraogo AR; Bopaka RG; Koumeka PP; Ossale Abacka KB; Mboussa J
    Rev Pneumol Clin; 2017 Oct; 73(5):217-224. PubMed ID: 29031963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis.
    Yan L; Xiao H; Zhang Q
    BMC Infect Dis; 2018 Oct; 18(1):512. PubMed ID: 30309331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary Tuberculosis.
    Nguyen MH; Levy NS; Ahuja SD; Trieu L; Proops DC; Achkar JM
    JAMA Netw Open; 2019 Feb; 2(2):e187617. PubMed ID: 30735231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults.
    Saranchuk P; Boulle A; Hilderbrand K; Coetzee D; Bedelu M; van Cutsem G; Meintjes G
    S Afr Med J; 2007 Jul; 97(7):517-23. PubMed ID: 17805454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cohort analysis for treatment outcomes TB pulmonary cases bacteriologically confirmed in Poland].
    Szczuka I
    Pneumonol Alergol Pol; 2005; 73(3):245-53. PubMed ID: 16989161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings.
    Harries AD; Banda HT; Boeree MJ; Welby S; Wirima JJ; Subramanyam VR; Maher D; Nunn P
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):999-1004. PubMed ID: 9869116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.